Federal Register / Vol. 63, No. 10 / Thursday, January 15, 1998 / Notices 2405

from the hospital, often 6 to 8 weeks

after birth), and a postdischarge stage

(from discharge home to approximately

1 year). Is there scientific evidence to

support more than one set of

micronutrient requirements for infant

formulas to support healthy growth and

development of the preterm infant at the

different stages of development? Are the

micronutrient requirements for term

infant formulas sufficient for thriving

postdischarge preterm infants?

(3) What is the scientific evidence to

support a dietary recommendation for a

minimum and a maximum quantitative

nutrient concentration for selenium,

chromium, molybdenum, and fluoride

in preterm infant formulas? What limits

of intake would ensure safe and

adequate exposure to these nutrients? Is

there a need to specify the chemical

form or other characteristics of these

nutrients or their sources to ensure

safety and adequacy?

(4) Certain micronutrient interactions,

such as vitamin E:linoleic acid, vitamin

B6:protein, and calcium:phosphorus,

have been identified for full-term

infants which have helped to ensure the

adequacy of full-term formulas. Are

there micronutrient interactions that can

be identified for preterm infants that

will help to ensure the nutrient

adequacy of infant formulas for this

population? Are there recommended

ratios for metal cations? Is the evidence

of interaction between these minerals

sufficiently strong to suggest that the

ratios should be ensured for the health

of preterm infants?

(5) In an earlier task under this

contract (61 FR 58566, November 15,

1996), LSRO/ASNS agreed to investigate

whether there is evidence of a benefit to

preterm infants from ingestion of

taurine and carnitine, as well as

whether there is evidence that would

provide a basis for a requirement for

minimal intakes of each of these

substances. Is there adequate evidence

of benefit of other substances not listed

in this notice to support a requirement

for their inclusion in preterm infant

formulas?

LSRO/ASNS will use these questions

as a guide in its investigation. ASNS

will prepare a comprehensive final

report that documents and summarizes

the results of its evaluation.

FDA and ASNS are announcing that

the LSRO/ASNS expects to hold a

public meeting on this topic on Friday,

March 27, 1998. The meeting will begin

at 9 a.m. It is anticipated that the public

meeting will be up to 1 day, depending

on the number of requests to make oral

presentations. Requests to make oral

presentations at the open meeting must

be submitted in writing and received by

Friday, February 13, 1998. Written

requests to make oral presentations of

scientific data, information, and views

at the open meeting should be

submitted both to Daniel J. Raiten

(address above) and to the Dockets

Management Branch (address above).

Two copies of the material to be

presented must be submitted to each

office on or before March 20, 1998. The

open meeting will be held in the Chen

Auditorium, Lee Bldg., ASNS (address

above).

FDA and ASNS are also inviting

submission of written presentations of

scientific data, information, and views.

These materials should be submitted on

or before July 1, 1998. Two copies of the

written materials must be submitted to

each office.

In accordance with its contract with

FDA, ASNS will provide the agency

with a scientific report on or about

September 30, 1998.

Dated: January 6, 1998.

William K. Hubbard,

Associate Commissioner for Policy

Coordination.

[FR Doc. 98–958 Filed 1–14–98; 8:45 am]

BILLING CODE 4160–01–F

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

Health Care Financing Administration

[Document Identifier: HCFA–9044]

Agency Information Collection

Activities: Submission for OMB

Review; Comment Request

AGENCY: Health Care Financing

Administration.

In compliance with the requirement

of section 3506(c)(2)(A) of the

Paperwork Reduction Act of 1995, the

Health Care Financing Administration

(HCFA), Department of Health and

Human Services, is publishing the

following summary of proposed

collections for public comment.

Interested persons are invited to send

comments regarding this burden

estimate or any other aspect of this

collection of information, including any

of the following subjects: (1) The

necessity and utility of the proposed

information collection for the proper

performance of the agency’s functions;

(2) the accuracy of the estimated

burden; (3) ways to enhance the quality,

utility, and clarity of the information to

be collected; and (4) the use of

automated collection techniques or

other forms of information technology to

minimize the information collection

burden.

Type of Information Collection

Request: Extension of a currently

approved collection; Title of

Information Collection: Provider

Reimbursement Manual, Part 1—

Chapter 27, Section 2721, 2722 and

2725, Request for Exception to ESRD

Composite Rates and Supporting

Regulations in 42 CFR 413.170; Form

No.: HCFA–9044 (OMB# 0938–0296);

Use: Sections 2721, 2722 and 2525 of

the Provider Reimbursement Manual

describe the information ESRD facilities

must submit in justifying an exception

request to their composite rate for

outpatient dialysis services.; Frequency:

On occasion; Affected Public: Business

or other for-profit, Not-for-profit

institutions and Federal Government;

Number of Respondents: 275; Total

Annual Responses: 275; Total Annual

Hours: 13,200.

To obtain copies of the supporting

statement and any related forms for the

proposed paperwork collections

referenced above, access HCFA’s Web

Site address at http://www.hcfa.gov/

regs/prdact95.htm, or E-mail your

request, including your address, phone

number, OMB number, and HCFA

document identifier, to

Paperwork@hcfa.gov, or call the Reports

Clearance Office on (410) 786–1326.

Written comments and

recommendations for the proposed

information collections must be mailed

within 30 days of this notice directly to

the OMB desk officer: OMB Human

Resources and Housing Branch,

Attention: Allison Eydt, New Executive

Office Building, Room 10235,

Washington, D.C. 20503.

Dated: January 7, 1998.

John P. Burke III,

HCFA Reports Clearance Officer, HCFA Office

of Information Services, Information

Technology Investment Management Group,

Division of HCFA Enterprise Standards.

[FR Doc. 98–1064 Filed 1–14–98; 8:45 am]

BILLING CODE 4120–03–P

DEPARTMENT OF THE INTERIOR

Fish and Wildlife Service

Endangered and Threatened Species

Permit Applications

AGENCY: Fish and Wildlife Service,

Interior.

ACTION: Notice of receipt of applications.

The following applicants have

applied for permits to conduct certain

activities with endangered species. This

notice is provided pursuant to section

10(c) of the Endangered Species Act of